A. Bollen

发表

Expression of multiple plasma membrane Ca(2+)-ATPases in rat pancreatic islet cells.

A. Herchuelz, A. Kamagaté, A. Bollen, 2000, Cell calcium.

New non nucleosidic phosphoramidites for the solid phase multi-labelling of oligonucleotides: Comb- and multifork-like structures

M. D. Vos, A. Bollen, A. V. Elsen, 1994 .

Selective detection of human papilloma virus DNAs by specific synthetic DNA probes.

A. Cravador, S. Houard, A. Bollen, 1989, Molecular and cellular probes.

Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality☆

J. Vilardaga, P. Robberecht, N. Moguilevsky, 1999, Peptides.

Monoclonal antibodies against plasma protease inhibitors: production and characterization of 15 monoclonal antibodies against human antithrombin III. Relation between antigenic determinants and functional sites of antithrombin III.

J. Urbain, A. Bollen, P. Hérion, 1985, Blood.

Recombinant Human Proapolipoprotein A-I: Experimental Strategies for the Production of an Authentic Molecule

C. Roobol, N. Moguilevsky, A. Bollen, 1993 .

One-step purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography.

D. Portetelle, A. Bollen, C. Glineur, 1982, Journal of immunological methods.

Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene.

C. Szpirer, J. Szpirer, M. Gillard, 1994, European journal of biochemistry.

Monoclonal antibodies against urokinase

J. Franssen, J. Urbain, A. Bollen, 1981, Bioscience reports.

Detection of Borrelia burgdorferi in biological samples using the polymerase chain reaction assay.

A. Bollen, P. Gautier, A. Herzog, 1991, Research in microbiology.

Specific identification of Bordetella pertussis by the polymerase chain reaction.

S. Houard, A. Bollen, A. Herzog, 1989, Research in microbiology.

Specific identification of Mycobacterium leprae by the polymerase chain reaction.

F. Portaels, S. Houard, A. Bollen, 1990, Molecular and cellular probes.

Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells.

J. Vilardaga, P. de Neef, P. Robberecht, 1995, European journal of pharmacology.

Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells.

J. Hénichart, M. Gillard, N. Moguilevsky, 1995, Journal of receptor and signal transduction research.

Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor.

P. de Neef, P. Robberecht, E. Di Paolo, 1999, Receptors & channels.

Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.

J. Vilardaga, P. de Neef, P. Robberecht, 1996, European journal of biochemistry.

The structural gene for the ribosomal protein S18 in Escherichia coli. II. Chemical studies on the protein S18 having an altered electrophoretic mobility.

M. Nomura, J. Zengel, A. Bollen, 1973, Journal of molecular biology.

NCX1 Na/Ca exchanger splice variants in pancreatic islet cells.

A. Herchuelz, A. Bollen, A. Bollen, 2001, The Journal of endocrinology.

NCX 1 Na / Ca exchanger splice variants in pancreatic islet cells

A. Herchuelz, A. Bollen, F. Eylen, 2001 .

Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function.

J. Vilardaga, P. de Neef, P. Robberecht, 1997, European journal of biochemistry.

Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin.

J. Vilardaga, P. de Neef, P. Robberecht, 1996, Biochemical and biophysical research communications.

Improved PCR method for high-efficiency site-directed mutagenesis using class 2S restriction enzymes.

J. Vilardaga, E. Di Paolo, A. Bollen, 1995, BioTechniques.

Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.

J. Vilardaga, P. de Neef, P. Robberecht, 1994, Molecular pharmacology.

Sensitivity and resistance to streptomycin in relation with factor‐mediated dissociation of ribosomes

A. Ghysen, A. Bollen, A. Herzog, 1971, FEBS letters.

The application of enzyme kinetics to the determination of dissociation constants for antigen-antibody interactions in solution.

M. Hoylaerts, M. D. de Broe, A. Bollen, 1990, Journal of immunological methods.

Ionic effects on the ribosomal quaternary structure.

A. Ghysen, A. Bollen, A. Herzog, 1970, European journal of biochemistry.

Molecular cloning, sequencing, and expression in Escherichia coli of human preprourokinase cDNA.

P. Chuchana, B. Colau, A. Cravador, 1985, DNA.

Expression in E. Coli of Human Preprourokinase cDNA

P. Chuchana, B. Colau, A. Cravador, 1985 .

Resistance to the peptide-like antibiotic negamycin in Escherichia coli.

R. Lavallé, A. Bollen, A. Herzog, 1981, Biochemical and biophysical research communications.

Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. II. Localization of the amino acid replacement in protein S17 from a meaA mutant.

M. Yaguchi, R. Villarroel, A. Bollen, 1976, Journal of molecular biology.

Correct in vivo processing of a chimeric ubiquitin-proapolipoprotein A-I fusion protein in baculovirus-infected insect cells.

N. Moguilevsky, A. Bollen, F. Varsalona, 1994, Journal of biotechnology.

Characterization of an amino‐acid substitution leading to spectinomycin resistance in Escherichia coli

A. Bollen, A. Herzog, 1971, FEBS letters.

Characterization of the 70 kDa polypeptide of the Na/Ca exchanger.

A. Herchuelz, A. Bollen, R. I. Saba, 1999, The Biochemical journal.

Purification of urokinase by monoclonal antibody affinity chromatography

A. Bollen, P. Hérion, 1983, Bioscience reports.

Monoclonal antibodies against plasma protease inhibitors: I. Production and characterization of 23 monoclonal antibodies against human α2

J. Urbain, A. Bollen, P. Hérion, 1984 .

Molecular cloning, sequencing and expression of a cDNA coding for human antithrombin III

M. Hoylaerts, B. Colau, A. Cravador, 1985 .

The ribosomal protein altered in spectinomycin resistant Escherichia coli

A. Bollen, A. Herzog, 1970, FEBS letters.

The structural gene for the ribosomal protein S18 in Escherichia coli. I. Genetic studies on a mutant having an alteration in the protein S18.

M. Nomura, J. Lecocq, J. Zengel, 1973, Journal of molecular biology.

Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.

J. Vilardaga, P. de Neef, P. Robberecht, 1995, Biochemical and biophysical research communications.

MUTANT AND CHIMAERIC RECOMBINANT PLASMINOGEN ACTIVATORS

M. Hoylaerts, D. Collen, A. Cravador, 1987, Thrombosis and Haemostasis.

A conditionally lethal mutation of Escherichia coli affecting the gene coding for ribosomal protein S2 (rpsB).

R. Lathe, J. Lecocq, R. Lavallé, 1979, Journal of molecular biology.

Construction and sequencing of new derivatives of the pIN-III-ompA secretion vector.

A. Bollen, A. V. Van Elsen, A. Fauconnier, 1998, Genetic analysis : biomolecular engineering.

Production of authentic human proapolipoprotein A-I in Escherichia coli: strategies for the removal of the amino-terminal methionine.

P. Gilles, N. Moguilevsky, A. Bollen, 1993, Journal of biotechnology.

High‐level production and isolation of human recombinant α1‐proteinase inhibitor in yeast

M. Hoylaerts, N. Harford, A. Bollen, 1986 .

High-level production and isolation of human recombinant alpha 1-proteinase inhibitor in yeast.

M. Hoylaerts, N. Harford, A. Bollen, 1986, FEBS letters.

Fluorescence studies on the 30 S ribosome assembly process

A. Favre, A. Bollen, A. Herzog, 1970, FEBS letters.

Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. I. General properties of neaA mutants.

R. Villarroel, A. Bollen, T. Cabezón, 1975, Journal of molecular biology.

Presence of NACA3 and NACA7 Exchanger Isoforms in Insulin‐Producing Cells

A. Herchuelz, A. Bollen, F. Eylen, 1996, Annals of the New York Academy of Sciences.

Flagellar flhA, flhB and flhE genes, organized in an operon, cluster upstream from the inv locus in Yersinia enterocolitica.

G. Cornelis, A. Bollen, A. Allaoui, 1997, Microbiology.

Complexity of the major surface protease (msp) gene organization in Leishmania (Viannia) braziliensis: evolutionary and functional implications

J. Dujardin, S. de Doncker, D. Le Ray, 2005, Parasitology.

Porcine D-amino acid oxidase: production of the biologically active enzyme in Escherichia coli.

M. Massaer, A. Cravador, A. Bollen, 1989, Biochemical and biophysical research communications.

Total DNA synthesis and cloning in Escherichia coli of a gene coding for the human growth hormone releasing factor.

B. Colau, A. Cravador, A. Bollen, 1985, Biochimie.

Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis

A. Bollen, C. Lockwood, N. Moguilevsky, 1995, Clinical and experimental immunology.

Solid-phase enzyme immunoassay of urokinase using monoclonal antibodies

D. Portetelle, J. Franssen, J. Urbain, 1983, Bioscience reports.